Sticker shock and the price of new therapies for hepatitis C: Is it worth it?

Authors

  • Nancy S. Reau,

    Corresponding author
    1. Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, IL
    • Address reprint requests to: N.S. Reau, M.D., Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, 5841 S. Maryland, MC7120, Chicago, IL 60637. E-mail: nreau@medicine.bsd.uchicago.edu.

    Search for more papers by this author
  • Donald M. Jensen

    1. Center for Liver Disease, Section of Gastroenterology, Hepatology and Nutrition, University of Chicago Medicine, Chicago, IL
    Search for more papers by this author

  • Potential conflict of interest: Dr. Reau consults for and received grants from Gilead and AbbVie. She consults for Idenix. She received grants from Janssen, Vertex, Genentech, Bristol-Myers Squibb, and Boehringer Ingelheim.

Ancillary